##  [Combination of Novartis drugs Tafinlar® and Mekinist® shows significant survival benefit in patients with metastatic melanoma](/us-en/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma-0 "Combination of Novartis drugs Tafinlar® and Mekinist® shows significant survival benefit in patients with metastatic melanoma") 

  May 31, 2015